Chapter 1 John F . Enders and Measles Virus Vaccine — a Reminiscence
نویسندگان
چکیده
Following their initial isolation in cell culture of the virus in 1954, a succession of investigators under the mentorship of John F. Enders conducted the research, development, and initial clinical studies responsible for the licensure in 1963 of a successful live attenuated measles virus vaccine. Propagation of the virus successively in human kidney cells, human amnion cells, embryonated hens’ eggs, and finally chick embryo cell cultures had selected virus that when inoculated into susceptible monkeys proved immunogenic without viremia or overt disease, in contrast to the early kidney cell-passaged material, which in similar monkeys produced viremia with illness mimicking human measles. Careful clinical studies in children by the Enders group and then by collaborating investigators in many sites established its safety, immunogenicity, and efficacy. This Edmonston strain measles virus became the progenitor of vaccines prepared, studied, and utilized throughout the United States and many other countries. With appreciation of measles morbidity and mortality, most marked among infants and children in the resource-limited lands, the vaccine was incorporated into the World Health Organization’s (WHO) Expanded Programme of Immunization (EPI) in 1974 along with BCG, OPV, and DTP. Successful efforts to further reduce measles’ burden were launched in 2001 and are continuing as the Measles Initiative (Partnership) under the leadership of the American Red Cross, International Red Cross, and Red Crescent societies, Centers for Disease Control (CDC), United Nations Children’s Fund (UNICEF), WHO, and the United Nations Foundation. D.E. Griffin and M.B.A. Oldstone (eds.) Measles – History and Basic Biology. 3 © Springer-Verlag Berlin Heidelberg 2009
منابع مشابه
John F. Enders and measles virus vaccine--a reminiscence.
Following their initial isolation in cell culture of the virus in 1954, a succession of investigators under the mentorship of John E Enders conducted the research, development, and initial clinical studies responsible for the licensure in 1963 of a successful live attenuated measles virus vaccine. Propagation of the virus successively in human kidney cells, human amnion cells, embryonated hens'...
متن کاملCultivation of measles virus in sheep kidney cells.
Since the first isolation of measles virus in human and monkey renal cells by Enders and Peebles (1), the virus has been grown in primary cultures of human amnion (5, 6), chick en\.bryo (3), dog kidney (2), bovine kidney (4,8), and guinea pig kidney (9). Sorne of these tissues have now even been employed for the production of measles vaccine. This report presents our data indicating the high su...
متن کاملEvaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350
Live attenuated recombinant measles vaccine virus (MV) Edmonston-Zagreb (EZ) strain was evaluated as a viral vector to express the ectodomains of fusion protein of respiratory syncytial virus (RSV F) or glycoprotein 350 of Epstein-Barr virus (EBV gp350) as candidate vaccines for prophylaxis of RSV and EBV. The glycoprotein gene was inserted at the 1(st) or the 3(rd) position of the measles viru...
متن کاملSequence Variation in Measles Virus F Gene of AIK-C Vaccines Strain after Passage in Vero Cells
متن کامل
The first measles vaccine.
Like in the more familiar story of polio vaccine, the development of the first successful live attenuated vaccine against measles began in the laboratory of John Enders. One of the greatest virologists of the 20th century, Enders pioneered the technique of viral tissue culture, which makes it possible to growviruses in vitro in cells nourished in laboratory media.1 In 1949, he and his pediatric...
متن کامل